KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $16.1 billion.

  • Eli Lilly's Receivables - Net rose 5646.15% to $16.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 billion, marking a year-over-year increase of 5646.15%. This contributed to the annual value of $11.0 billion for FY2024, which is 2106.81% up from last year.
  • Latest data reveals that Eli Lilly reported Receivables - Net of $16.1 billion as of Q3 2025, which was up 5646.15% from $14.2 billion recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Receivables - Net ranged from a high of $16.1 billion in Q3 2025 and a low of $5.6 billion during Q1 2021
  • Moreover, its 5-year median value for Receivables - Net was $7.5 billion (2023), whereas its average is $8.7 billion.
  • Per our database at Business Quant, Eli Lilly's Receivables - Net surged by 334.49% in 2022 and then skyrocketed by 5646.15% in 2025.
  • Eli Lilly's Receivables - Net (Quarter) stood at $6.7 billion in 2021, then grew by 3.34% to $6.9 billion in 2022, then skyrocketed by 31.82% to $9.1 billion in 2023, then increased by 21.07% to $11.0 billion in 2024, then soared by 46.36% to $16.1 billion in 2025.
  • Its last three reported values are $16.1 billion in Q3 2025, $14.2 billion for Q2 2025, and $12.0 billion during Q1 2025.